NOVARTIS AG

Drug Name	Phase	Indication	Designations	Patent
Meningococcal ACWY conjugate vaccine	Phase 3	Bacterial Meningitis	-	-
Valsartan	Phase 3	Hypertension	-	-
Nilotinib	Phase 3	Chronic Myelogenous Leukemia	-	-
FTY720	Phase 3	Multiple Sclerosis	-	-
pioglitazone	Phase 3	Diabetes Mellitus, Type 2	-	-
Fulvestrant	Phase 3	Breast Cancer	-	-
eltrombopag	Phase 3	Immune Thrombocytopenic Purpura (ITP)	-	-
Erenumab	Phase 3	Episodic Migraine	-	-
Metformin	Phase 3	Diabetes Mellitus, Type 2	-	-
agomelatine	Phase 3	Major Depressive Disorder (MDD)	-	-
Diclofenac Sodium	Phase 3	Acute Ankle Sprain	-	-
Everolimus	Phase 3	Tuberous Sclerosis	-	-
Famciclovir	Phase 3	Herpes Labialis	-	-
Certoparin	Phase 3	Renal Dialysis	-	-
Inclisiran	Phase 3	Atherosclerotic Cardiovascular Disease	-	-
Alpelisib	Phase 3	Breast Neoplasms	-	-
Glimepiride	Phase 3	Type II Diabetes Mellitus	-	-
ACZ885	Phase 3	Pulmonary Sarcoidosis	-	-
asciminib	Phase 3	Chronic Myelogenous Leukemia - Chronic Phase	-	-
Everolimus (RAD001)	Phase 3	Renal Transplantation	-	-
Salbutamol/albuterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Lansoprazole	Phase 3	Frequent Heartburn	-	-
Aliskiren/HCTZ	Phase 3	Hypertension	-	-
Pimecrolimus Cream 1%	Phase 3	Chronic Hand Dermatitis	-	-
Telbivudine (LdT)	Phase 3	Chronic Hepatitis B	-	-
VAY736	Phase 3	Sjogren Syndrome	-	-
Certican	Phase 3	Kidney Transplantation	-	-
Vildagliptin AM	Phase 3	Diabetes Mellitus, Type 2	-	-
terbinafine	Phase 3	Onychomycosis	-	-
Monovalent A/H1N1 influenza vaccine	Phase 3	Pandemic Influenza	-	-
CTL019	Phase 3	Acute Lymphoblastic Leukemia	-	-
imatinib mesylate	Phase 3	Leukemia	-	-
deferasirox	Phase 3	Non-transfusion Dependent Thalassemia	-	-
Ranibizumab 0.5 mg	Phase 3	Proliferative Diabetic Retinopathy (PDR)	-	-
telbivudine	Phase 3	Chronic Hepatitis B	-	-
Meningococcal C Conjugate Vaccine	Phase 3	Prevention of Meningococcal Infection	-	-
RLX030	Phase 3	Acute Heart Failure	-	-
secukinumab (AIN457)	Phase 3	Rheumatoid Arthritis	-	-
Ianalumab	Phase 3	Primary Immune Thrombocytopenia (ITP)	-	-
Olmesartan medoxomil	Phase 3	Hypertension	-	-
Tacrolimus	Phase 3	Kidney Diseases	-	-
trivalent split influenza vaccine	Phase 3	Seasonal Influenza	-	-
Focalin XR	Phase 3	ADHD	-	-
Everolimus + reduced tacrolimus	Phase 3	Liver Transplantation	-	-
Octreotide	Phase 3	Acromegaly	-	-
Pelacarsen	Phase 3	Atherosclerotic Cardiovascular Disease (ASCVD)	-	-
Enteric-Coated Mycophenolate Sodium	Phase 3	Prevention of Acute Rejection After Kidney Transplantation	-	-
Pazopanib	Phase 3	Ovarian Cancer	-	-
Pimecrolimus	Phase 3	Keratoconjunctivitis Sicca	-	-
MenACWY-CRM	Phase 3	Meningococcal Disease	-	-
LCQ908	Phase 3	Familial Chylomicronemia Syndrome (FCS)	-	-
Imatinib	Phase 3	Chronic Myelogenous Leukemia in Chronic Phase	-	-
Darifenacin	Phase 3	Overactive Bladder Syndrome	-	-
rivastigmine transdermal patch	Phase 3	Alzheimer's Disease	-	-
Pasireotide	Phase 3	Cushing's Disease	-	-
Indacaterol 150 μg	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Octreotide LAR	Phase 3	Acromegaly	-	-
Agomelatine (AGO178C)	Phase 3	Major Depressive Disorder	-	-
osilodrostat	Phase 3	Cushings Disease	-	-
Ofatumumab	Phase 3	Relapsing Multiple Sclerosis	-	-
Letrozole	Phase 3	Breast Cancer	-	-
LCZ696	Phase 3	Hypertension	-	-
Fingolimod 1.25 mg	Phase 3	Multiple Sclerosis	-	-
Physicians' Choice	Phase 3	Leukaemia	-	-
Olmesartan	Phase 3	Essential Hypertension	-	-
Siponimod	Phase 3	Multiple Sclerosis (MS)	-	-
Ranibizumab (RFB002)	Phase 3	Diabetic Macular Edema	-	-
Dabrafenib	Phase 3	Neoplasms, Brain	-	-
Indacaterol 150 µg	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
valsartan + amlodipine	Phase 3	Hypertension	-	-
Ustekinumab	Phase 3	Psoriatic Arthritis	-	-
Alcon Investigational Agent	Phase 3	Open-Angle Glaucoma	-	-
Anecortave Acetate 15 mg sterile suspension	Phase 3	Macular Degeneration	-	-
Secukinumab 300 mg	Phase 3	Chronic Scalp Psoriasis	-	-
Salmeterol 50 μg	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
AIN457	Phase 3	Plaque-type Psoriasis	-	-
Valsartan/amlodipine 80/5 mg	Phase 3	Hypertension	-	-
iptacopan	Phase 3	IC-MPGN	-	-
rMenB+OMV NZ	Phase 3	Prevention of the Meningococcal Disease	-	-
Brolucizumab	Phase 3	Diabetic Macular Edema	-	-
valsartan/amlodipine	Phase 3	Hypertension	-	-
Panobinostat	Phase 3	Cutaneous T-Cell Lymphoma	-	-
Nepafenac Ophthalmic Suspension, 0.1%	Phase 3	Cataract	-	-
Haemophilus influenzae type b (Hib) vaccine	Phase 3	Haemophilus Influenzae Type b (Hib) Infection	-	-
NIS793	Phase 3	Metastatic Pancreatic Ductal Adenocarcinoma	-	-
Hydrochlorothiazide	Phase 3	Hypertension	-	-
MenACWY-CRM197	Phase 3	Meningitis	-	-
vildagliptin + metformin	Phase 3	Diabetes Mellitus, Type 2	-	-
Basiliximab	Phase 3	Liver Transplant	-	-
Indacaterol 300 µg	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
BION-1301	Phase 3	IgA Nephropathy	-	-
LNP023	Phase 3	Paroxysmal Nocturnal Hemoglobinuria (PNH)	-	-
Ruxolitinib	Phase 3	Cytokine Storm (Covid-19)	-	-
Ligelizumab	Phase 3	Chronic Spontaneous Urticaria	-	-
AMN107	Phase 3	Leukemia, Myeloid, Chronic	-	-
QAB149	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Tobramycin inhalation powder	Phase 3	Pulmonary Infections	-	-
LOU064	Phase 3	Chronic Spontaneous Urticaria	-	-
Bosutinib	Phase 3	Chronic Myelogenous Leukemia	-	-
MF59-eH1N1_f	Phase 3	Influenza	-	-
Glycopyrronium bromide	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Fingolimod	Phase 3	Multiple Sclerosis	-	-
dovitinib	Phase 3	Solid Tumors	-	-
Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine	Phase 3	Swine-Origin Influenza A H1N1 Virus	-	-
EXE844 Sterile Otic Suspension, 0.3%	Phase 3	Otitis Media With Effusion in Children	-	-
Influenza virus vaccine	Phase 3	Influenza	-	-
Enalapril	Phase 3	Hypertension	-	-
Paclitaxel	Phase 3	Breast Cancer	-	-
secukinumab 150 mg	Phase 3	Moderate to Severe Chronic Plaque-type Psoriasis	-	-
Rivastigmine	Phase 3	Vascular Dementia	-	-
Sitagliptin	Phase 3	Diabetes Mellitus, Type 2	-	-
Indacaterol 300 μg	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Formoterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Mycophenolate mofetil (MMF)	Phase 3	Kidney Transplantation	-	-
Secukinumab (75 mg)	Phase 3	Psoriatic Arthritis	-	-
Remibrutinib	Phase 3	Chronic Spontaneous Urticaria	-	-
Formoterol (12 µg b.i.d.)	Phase 3	Pulmonary Disease, Chronic Obstructive	-	-
Nilotinib (AMN107)	Phase 3	Gastrointestinal Stromal Tumor (GIST)	-	-
NVA237	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Prednisone	Phase 3	Renal Transplantation	-	-
Lapatinib	Phase 3	Breast Neoplasms	-	-
LCZ696 (Sacubitril/Valsartan)	Phase 3	Chronic Heart Failure With Reduced Ejection Fraction	-	-
Exemestane	Phase 3	Breast Cancer	-	-
QVA149	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
vildagliptin	Phase 3	Diabetes Mellitus, Type 2	-	-
ranibizumab	Phase 3	Neovascular Age-related Macular Degeneration	-	-
TIVc	Phase 3	Influenza	-	-
Omalizumab	Phase 3	Asthma	-	-
QVM149	Phase 3	Asthma	-	-
secukinumab	Phase 3	Juvenile Psoriatic Arthritis	-	-
Tegaserod	Phase 3	Dyspepsia	-	-
aliskiren	Phase 3	Hypertension	-	-
Indacaterol	Phase 3	Asthma	-	-
Zoledronic acid	Phase 3	Breast Cancer With Bone Metastasis	-	-
Tiotropium	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
inclisiran sodium	Phase 3	Hypercholesterolemia	-	-
Tamoxifen	Phase 3	Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women	-	-
Anastrozole	Phase 3	Breast Cancer	-	-
Mycophenolate sodium (enteric coated)	Phase 3	Renal Transplant	-	-
capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)	Phase 3	Parkinson's Disease	-	-
Canakinumab pre-filled syringe	Phase 3	Acute Gouty Arthritis	-	-
amlodipine	Phase 3	Hypertension	-	-
Sunitinib	Phase 3	Carcinoma, Renal Cell	-	-
Diclofenac topical sodium gel 1%	Phase 3	Osteoarthritis	-	-
Pelabresib	Phase 3	Myelofibrosis	-	-
Ribociclib	Phase 3	Breast Cancer	-	-
TQJ230	Phase 3	Cardiovascular Disease and Lipoprotein(a)	-	-
valsartan plus hydrochlorothiazide	Phase 3	Hypertension	-	-
Trametinib	Phase 3	Melanoma and Brain Metastases	-	-
Pasireotide LAR	Phase 3	Acromegaly	-	-
RAD001	Phase 3	Carcinoma	-	-
QAW039	Phase 3	Asthma	-	-
Lumiracoxib	Phase 3	Knee Osteoarthritis	-	-
Licarbazepine	Phase 3	Bipolar Disorder	-	-
Onasemnogene Abeparvovec-xioi	Phase 3	Spinal Muscular Atrophy Type I	-	-
Canakinumab	Phase 3	Rheumatoid Arthritis	-	-
Enteric-coated Mycophenolate sodium (EC-MPS)	Phase 3	Liver Transplantation	-	-
Artemether-lumefantrine	Phase 3	Plasmodium Falciparum Malaria	-	-
Investigator choice of chemotherapy	Phase 2	Nasopharyngeal Carcinoma	-	-
Sandostatin LAR Depot	Phase 2	Primary Insulin Hypersecretion	-	-
LFG316	Phase 2	Neovascular Age-elated Macular Degeneration (Wet AMD)	-	-
LDE225 0.25%	Phase 2	Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients	-	-
Hydrochlorothiazide (HCTZ)	Phase 2	Essential Hypertension	-	-
inhaled corticosteroid therapy	Phase 2	Bronchial Asthma	-	-
QGE031	Phase 2	Asthma	-	-
CAD106	Phase 2	Alzheimer Disease	-	-
TIV	Phase 2	Human Influenza	-	-
bimagrumab	Phase 2	Muscle Wasting (Atrophy) After Hip Fracture Surgery	-	-
BGG492	Phase 2	Adrenocortical Adenoma	-	-
Midostaurin	Phase 2	Acute Myeloid Leukemia	-	-
SBR759	Phase 2	Chronic Kidney Disease	-	-
Iptacopan (LNP023)	Phase 2	Age-Related Macular Degeneration	-	-
Investigational new drug, company code: BGG492	Phase 2	Seizures	-	-
AHU377	Phase 2	Systolic Hypertension	-	-
rMenB	Phase 2	Meningococcal Disease	-	-
Surface Antigen, Inactivated, Influenza (form.2006-07)	Phase 2	Influenza	-	-
BKM120	Phase 2	HER2-positive Newly Diagnosed, Primary Breast Cancer	-	-
Investigational Treatment	Phase 2	Actinic Keratosis	-	-
BYM338	Phase 2	Sporadic Inclusion Body Myositis	-	-
Nidufexor	Phase 2	Diabetic Nephropathy	-	-
AIN457A	Phase 2	Psoriatic Arthritis	-	-
DNK333 5 mg	Phase 2	Pruritus in Patients With Atopic Dermatitis	-	-
ECMPS-IEM	Phase 2	Detection Accuracy	-	-
CJM112	Phase 2	Asthma	-	-
PDR001	Phase 2	Small Cell Lung Cancer	-	-
VHB937	Phase 2	Alzheimer's Disease	-	-
CFZ533	Phase 2	Sjögren Syndrome	-	-
GIA632	Phase 2	Non-segmental Vitiligo	-	-
ramipril	Phase 2	Heart Failure	-	-
LYS006 20 mg	Phase 2	Inflammatory Acne	-	-
Patupilone	Phase 2	Hepatocellular Carcinoma	-	-
AEE788	Phase 2	Glioblastoma Multiforme	-	-
Montelukast	Phase 2	Allergic Rhinitis	-	-
Adjuvanted H5N1 pandemic influenza vaccine	Phase 2	Pandemic H5N1 Influenza	-	-
Clozapine	Phase 2	Schizophrenia	-	-
indacaterol/glycopyrrolate	Phase 2	Chronic Obstructive Pulmonary Disease (COPD)	-	-
prednisolone	Phase 2	Healthy	-	-
QMF149	Phase 2	COPD	-	-
Cyclosporine	Phase 2	Severe Aplastic Anemia	-	-
Capmatinib	Phase 2	Non-Small Cell Lung Cancer (NSCLC)	-	-
SAF312	Phase 2	Chronic Ocular Pain	-	-
Seasonal Influenza Vaccine	Phase 2	Influenza	-	-
Trivalent influenza virus vaccine (TIV)	Phase 2	Human Influenza	-	-
Adjuvanted influenza vaccine	Phase 2	Influenza Disease	-	-
LDK378	Phase 2	Non-Small-Cell Lung Cancer	-	-
BAF312	Phase 2	Relapsing Remitting Multiple Sclerosis	-	-
TKI258	Phase 2	Melanoma	-	-
Deferasirox (ICL670)	Phase 2	Iron Overload	-	-
Serelaxin	Phase 2	Acute Heart Failure	-	-
LHW090	Phase 2	Chronic Kidney Disease (CKD)	-	-
MAS825	Phase 2	Coronary Heart Disease	-	-
LIK066	Phase 2	Polycystic Ovary Syndrome	-	-
LEE011	Phase 2	Tumors With CDK4/6 Pathway Activation	-	-
CMK389	Phase 2	Pulmonary Sarcoidosis	-	-
MCS110	Phase 2	Triple Negative Breast Cancer	-	-
influenza vaccine	Phase 2	Influenza	-	-
crizanlizumab	Phase 2	Sickle Cell Disease (SCD)	-	-
Aliskiren 300 mg	Phase 2	Post Acute Coronary Syndrome	-	-
LCI699	Phase 2	Hypertension	-	-
AQW051	Phase 2	Schizophrenia	-	-
Bendamustine	Phase 2	Chronic Lymphocytic Leukemia (CLL)	-	-
Spartalizumab	Phase 2	Advanced Hepatocellular Carcinoma	-	-
DFV890	Phase 2	Symptomatic Knee Osteoarthritis	-	-
TCH346	Phase 2	Amyotrophic Lateral Sclerosis	-	-
Mometasone furoate	Phase 2	Asthma	-	-
LYS006	Phase 2	Hidradenitis Suppurativa	-	-
QAX576	Phase 2	Allergic Rhinitis	-	-
DNK333	Phase 2	Irritable Bowel Syndrome	-	-
Cryptosporidium parvum oocysts (ABO809)	Phase 2	Cryptosporidiosis	-	-
HSC835	Phase 2	Single Umbilical Cord Blood Transplantation	-	-
fluticasone propionate/salmeterol	Phase 2	Asthma	-	-
INC424	Phase 2	Primary Myelofibrosis	-	-
Atrasentan	Phase 2	IgA Nephropathy	-	-
LDE225	Phase 2	Medulloblastoma	-	-
AFQ056	Phase 2	Dyskinesias	-	-
rapcabtagene autoleucel	Phase 2	Lupus Erythematosus, Systemic	-	-
AEB071	Phase 2	Kidney Transplantation	-	-
TIN816 70 mg lyophilisate powder	Phase 2	Acute Kidney Injury Due to Sepsis	-	-
cetuximab	Phase 2	KRAS G12C Mutant Solid Tumors	-	-
epothilone b	Phase 2	Colorectal Neoplasms	-	-
ranibizumab 0.5mg	Phase 2	Choroidal Neovascularisation	-	-
CDZ173	Phase 2	Primary Sjögren's Syndrome	-	-
AAE581	Phase 2	Osteoporosis	-	-
JDQ443	Phase 2	Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation	-	-
Monovalent inactivated influenza vaccine	Phase 2	Prepandemic Influenza Vaccine	-	-
Triamcinolone acetonide	Phase 2	Acute Gout	-	-
Capecitabine	Phase 2	Breast Cancer	-	-
Eltrombopag 12.5 mg	Phase 2	Cytopaenia	-	-
[177Lu]Lu-PSMA-617	Phase 2	Metastatic Castration-Resistant Prostate Cancer (mCRPC)	-	-
PKN605	Phase 2	Atrial Fibrillation	-	-
rapcabtagene autoleucel (YTB323)	Phase 2	Relapsing Multiple Sclerosis	-	-
Vinorelbine	Phase 2	Cancer	-	-
LAG525	Phase 2	Melanoma	-	-
YTB323	Phase 2	Systemic Lupus Erythematosus	-	-
QBW251	Phase 2	Chronic Obstructive Pulmonary Disease, COPD	-	-
ICL670	Phase 2	Sickle Cell Disease	-	-

Regulatory Approvals

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

NOVARTIS AG

Market Overview

NVSEF News

Catalyst Timeline

Ianalumab Phase 3 Results Expected

Pipeline & FDA Submissions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals